NCT04338711 A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) Formulations Status COMPLETED Phase PHASE1
NCT04338204 Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden Status RECRUITING Phase N/A
NCT04337138 A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World Status COMPLETED Phase N/A
NCT04332744 Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First) Status COMPLETED Phase PHASE2
NCT04332107 Azithromycin for COVID-19 Treatment in Outpatients Nationwide Status TERMINATED Phase PHASE3
NCT04331678 Evaluation of a Mobile App to Promote Social Support for Oncology Patients Status COMPLETED Phase NA
NCT04325698 A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC Status TERMINATED Phase PHASE3
NCT04323124 Study of Single and Multiple Ascending Doses of PF-07059013 in Healthy Adult Participants Status TERMINATED Phase PHASE1
NCT04321031 Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) Status COMPLETED Phase PHASE2
NCT04309617 Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy Status COMPLETED Phase N/A
NCT04307576 A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Status RECRUITING Phase PHASE3
NCT04305587 Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT04299048 Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. Status COMPLETED Phase PHASE1
NCT04297384 Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice Status COMPLETED Phase NA
NCT04286412 Nonacog Alfa Prophylaxis And Treatment Of Bleeding Episodes In Previously Treated Patients With Hemophilia B Status COMPLETED Phase PHASE4
NCT04281485 Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04269538 Evaluation of Safety, Tolerability and Pharmacokinetics of Single Dose of PF-06480605 in Japanese Healthy Participants Status COMPLETED Phase PHASE1